Development and validation of a reversed-phase liquid chromatographic method with fluorescence detection for the study of Saquinavir pharmacokinetics in rat plasma

Analytica Chimica Acta

Volumn 594, Issue 2, 2007, Pages 248-256

  Pathak, Shriram M ^a   Kumar, A Ranjith ^a   Subramanian, G ^a   Udupa, N ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Fluorescence; Pharmacokinetics; Rat plasma; Saquinavir; Validation

Indexed keywords

BODY FLUIDS; FLUORESCENCE; HIGH PRESSURE LIQUID CHROMATOGRAPHY; RATS;

BIOAVAILABILITY; RAT PLASMA; SAQUINAVIR; VALIDATION;

PHARMACOKINETICS;

POTASSIUM DIHYDROGEN PHOSPHATE; SAQUINAVIR;

ACCURACY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENCE; HIV PROTEASE INHIBITORS; MALE; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SAQUINAVIR;

RATTUS;

EID: 34250655363     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2007.05.028     Document Type: Article

References (24)

1. Palella F.J., Delaney K.M., and Moorman A.C. New Engl. J. Med. 338 (1998) 853
2. Noble S., and Faulds D. Drugs 52 (1996) 93
3. Condra J.H., Petropoulos C.J., Ziermann R., Schleif W.A., Shivaprakash M., and Emini E.A. J. Infect. Dis. 182 (2000) 758
4. Gisolf E.H., van Heeswijk R.P., Hoetelmans R.W., and Danner S.A. AIDS 14 (2000) 801
5. Langmann P., Zilly M., Weissbrich B., Schlor C., Vath T., Richter E., and Klinker H. Eur. J. Med. Res. 5 (2000) 59
6. Reiser M., Salzberger B., Stiepel A., Hoetelmans R., Diehl V., and Fatkenheuer G. Eur. J. Med. Res. 4 (1999) 54
7. Kupferschmidt H.H., Fattinger K.E., Ha H.R., Follath F., and Krahenbuhl S. Br. J. Clin. Pharmacol. 45 (1998) 355
8. Mouly S.J., Paine M.F., and Watkins P.B. J. Pharmacol. Exp. Ther. 308 (2004) 941
9. Fitzsimmons M.E., and Collins M.M. Drug Metab. Dispos. 25 (1997) 256
10. Kim A.E., Dintaman J.M., Waddell D.S., and Silverman J.A. J. Pharmacol. Exp. Ther. 286 (1998) 1439
11. Sankatsing S.C., Beijnen J.H., Schinkel A.H., and Prins J.M. J. Antimicrob. Chemother. 48 (2004) 1073
12. Benet L.Z., Cummins C.L., and Wu C.Y. Int. J. Pharm. 277 (2004) 3
13. Notari S., Bocedi A., Ippolito G., Narciso P., Pucillo L.P., Tossini G., Donnorso R.P., Gasparrini F., and Ascenzi P. J. Chromatogr. B 831 (2006) 258
14. Verbesselt R., Wijngaerden E.V., and de Hoon J. J. Chromatogr. B 845 (2007) 51
15. Choi S.O., Rezk N.L., and Kashuba A.D.M. J. Pharm. Biomed. Anal. 43 (2007) 1562
16. Rebiere H., Mazel B., Civade C., and Bonnet P.A. J. Chromatogr. B 850 (2007) 376
17. Weller D.R., Brundage R.C., Balfour H.H., and Vezina H.E. J. Chromatogr. B 848 (2007) 369
18. Dickinson L., Robinson L., Tjia J., Khoo S., and Back D. J. Chromatogr. B 829 (2005) 82
19. Pereira E.A., Micke G.A., and Tavares M.F. J. Chromatogr. A 1091 (2005) 169
20. Guidance for industry Bioanalytical Method Validation, Food and Drug Administration (FDA), Department of Health and Human Services, Rockville, MD, 2001.
21. Ha H.R., Follath F., Bloemhard Y., and Krahenbuhl S. J. Chromatogr. B 694 (1997) 427
22. Weitschies W., Bernsdorf A., Giessmann T., Zschiesche M., Modess C., Hartmann V., Mrazek C., Wegner D., Nagel S., and Siegmund W. Pharm. Res. 22 (2005) 728
23. Fukuyama T., Yamaoka K., Ohata Y., and Nakagawa T. Drug. Metab. Dispos. 22 (1994) 479
24. Shang E., Xiang B., Xie G.L.S., Wei W., and Lu J. Anal. Bioanal. Chem. 382 (2005) 216